The DOI matches its Crossref record; 380 of the 385 references it cites were found in a registry or an index.
The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
Open accessAbstract
The liver is a dynamic organ that plays critical roles in many physiological processes, including the regulation of systemic glucose and lipid metabolism. Dysfunctional hepatic lipid metabolism is a cause of nonalcoholic fatty liver disease (NAFLD), the most common chronic liver disorder worldwide, and is closely associated with insulin resistance and type 2 diabetes. Through the use of advanced mass spectrometry “omics” approaches and detailed experimentation in cells, mice, and humans, we now understand that the liver secretes a wide array of proteins, metabolites, and noncoding RNAs (miRNAs) and that many of these secreted factors exert powerful effects on metabolic processes both in the liver and in peripheral tissues. In this review, we summarize the rapidly evolving field of “hepatokine” biology with a particular focus on delineating previously unappreciated communication between the liver and other tissues in the body. We describe the NAFLD-induced changes in secretion of liver proteins, lipids, other metabolites, and miRNAs, and how these molecules alter metabolism in liver, muscle, adipose tissue, and pancreas to induce insulin resistance. We also synthesize the limited information that indicates that extracellular vesicles, and in particular exosomes, may be an important mechanism for intertissue communication in normal physiology and in promoting metabolic dysregulation in NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with ~2,500 liver-secreted proteins identified using modern liquid chromatography and mass spectroscopy technologies39.”
From Exerkines in health, resilience and disease (2022) · cites this paper as [39]
In the citing paper
“These exerkines affect glucose and/or lipid metabolism (for example, angiopoietin-like protein 4 in humans and animal models39,79), browning of WAT (FGF21 in a mouse model106), lipolysis (FGF21 in humans and a mouse model77) and the maintenance of cellular homeostasis (heat shock protein 72 in humans107).”
From Exerkines in health, resilience and disease (2022) · cites this paper as [39]
In the citing paper
“fetuin-A worsens peripheral insulin resistance by reducing insulin signalling and glucose transporter type 4 trafficking39.”
From Exerkines in health, resilience and disease (2022) · cites this paper as [39]
In the citing paper
“Activin-E is elevated in the livers and serum of humans with obesity and NAFLD (Table 1) [29]”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [29]
In the citing paper
“Furthermore, knockdown of FST in mice improved insulin sensitivity [29,196].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [29]
In the citing paper
“Hepassocin has also been implicated in skeletal muscle insulin resistance through an AMPK-dependent mechanism [29] (Figure 3).”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [29]
In the citing paper
“These findings coincide with studies in mice that demonstrate increased hepatic expression of SeP in response to high-fat diet feeding, NAFLD, and type 2 diabetes [29,260,265].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
Mammalian microRNAs predominantly act to decrease target mRNA levels
Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010) · Nature · doi:10.1038/nature09267 · Cited by 3,886
Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes
Trajković, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brügger, B., & Simons, M. (2008) · Science · doi:10.1126/science.1153124 · Cited by 3,760
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Research works printed but not linked: 1
- Berglund, 2009, Fibroblast growth fact or 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity, 4084
Cited by
Sorted by citations
Items 301–400 of 620
Self-assembly drug-albumin nanocomposites for nonalcoholic fatty liver disease treatment
Jing, W., Jiang, M., Fu, X., Yang, J., Chen, L., Leng, F., Xu, P., Huang, W., Yu, C., & Yang, Z. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.06.167 · Cited by 9
Kazeminasab, F., Baharlooie, M., Rezazadeh, H., Soltani, N., & Rosenkranz, S. K. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114340 · Cited by 10
Liu, G., Yang, L., Tang, Y.-F., Lin, J.-C., Wang, F., Shen, J., Chang, B., & Kong, X.-N. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117330 · Cited by 9
Wang, S., Gao, H., Lin, P., Qian, T., & Xu, L. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03386-6 · Cited by 10
H3K9me3 demethylation by JMJD2B is regulated by pirfenidone resulting in improved NASH
Rodríguez-Sanabria, J. S., Rosas-Campos, R., Vázquez-Esqueda, Á. O., Palacios‐Marin, I., Jiménez‐Chillarón, J. C., Escutia-Gutiérrez, R., Jave‐Suárez, L. F., Galicia‐Moreno, M., Monroy-Ramírez, H. C., Reyes, E. C., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-75458-2 · Cited by 9
Zhang, Q., Liu, Z., Zhang, J., Yang, S., & Liu, L. (2025) · Scientific Reports · doi:10.1038/s41598-024-84917-9 · Cited by 9
Li, P., Wu, Q., Zhou, Y., Hu, X., Tang, Y., Wang, Y.-Y., Fan, W., Shan, Y., Yu, K., Wang, J., et al. (2025) · Nano Research · doi:10.26599/nr.2025.94907986 · Cited by 9
Bian, H., Ma, J., Qu, S., Qian, J., Hao, C., Liu, C., & Gao, X. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-10013-6 · Cited by 9
Ma, C., Wang, C., Zhang, Y., Zhou, H., & Li, Y. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467215666211217120448 · Cited by 8
Takeishi, R., Misaka, T., Ichijo, Y., Ishibashi, S., Matsuda, M., Yamadera, Y., Ohara, H., Sugawara, Y., Hotsuki, Y., Watanabe, K., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024901 · Cited by 9
Protein Targeting to Glycogen (PTG): A Promising Player in Glucose and Lipid Metabolism
Deng, X., Wang, C., Xia, Y., & Yuan, G. (2022) · Biomolecules · doi:10.3390/biom12121755 · Cited by 9
Montgomery, M. K., Nardo, W. D., & Watt, M. J. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00178.2023 · Cited by 8
Self-citationGarcía-Beltrán, C., Peyrou, M., Navarro‐Gascon, A., López‐Bermejo, A., de Zegher, F., Villarroya, F., & Ibáñez, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1325230 · Cited by 8
Leng, X., Liao, W., & Zheng, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-63646-z · Cited by 11
Luo, H., Xing, L., Fu, T., Xiao, S., & Fan, L. (2024) · BMC Public Health · doi:10.1186/s12889-024-20742-z · Cited by 10
Zhang, Y., Su, F., Zhu, E.-L., Sun, Y., Kuang, H., & Wang, Q. (2025) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2025.01.003 · Cited by 8
Hepatokines and their role in cardiohepatic interactions in heart failure
Shouman, W. A., Najmeddine, S., Sinno, L., Nehme, R. D., Ghawi, A. E., Ziade, J. A., Altara, R., Amin, G., Booz, G. W., & Zouein, F. A. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177356 · Cited by 9
Liu, W., Sun, M. J., Zhang, H., Wang, W., Song, J., Wang, M.-Y., Wang, C., & Sun, H.-M. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141660 · Cited by 10
Tunable Synthetic Hydrogel Modulates Hepatic Lineage Specification of Human Liver Organoid
Wang, L., Riediger, L., Rao, Q., Xu, X., Nie, Y., Zhou, Y., Zhang, J., Tang, P., Wang, W., Tacke, F., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202508430 · Cited by 11
Astaxanthin-Based Biomaterials for Tissue Repair and Drug Delivery Systems
Wang, Y., Xue, H., Sun, C., Gu, Q., Chen, L., Lin, Z., Xu, L., Lei, L., Li, Q., & Zhao, Z. (2025) · Biomaterials Research · doi:10.34133/bmr.0282 · Cited by 8
Zeng, X., Xie, S., Jiang, F., Li, X., Li, M., Zhang, T., Zhang, Y., Rao, S., Mo, Y., Zhang, H., et al. (2023) · British Journal Of Nutrition · doi:10.1017/s0007114523000818 · Cited by 8
Parvanova, A. I., Abbate, M., Yáñez, A. M., Bennasar‐Veny, M., López‐González, Á. A., Ramírez‐Manent, J. I., Iliev, I. P., Fresneda, S., Arias-Fernández, M., Remuzzi, G., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110729 · Cited by 8
Zheng, J.-H., Lin, S., Li, X., Shen, C., Zheng, S., & Chen, W.-B. (2023) · Journal of Food Biochemistry · doi:10.1155/2023/5273349 · Cited by 8
Tao, Q., Ma, N., Fan, L., Ge, W., Zhang, Z., Liu, X., Li, J., & Yang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042141 · Cited by 8
Lan, T., Wu, J., Tang, B., He, X., Ding, X., Ren, X., Fu, Y., Yuan, Q., Liu, W., Wang, S., et al. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106247 · Cited by 8
Zhu, X., Yin, H., Han, J., Zhang, X., Han, Q., Sun, W., Liu, Y., Tao, W., Liu, X., Wang, G., et al. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s520688 · Cited by 8
The Troubling Link Between Non-alcoholic Fatty Liver Disease (NAFLD) and Extrahepatic Cancers (EHC)
Venniyoor, A., Farsi, A. M. A., & Bahrani, B. J. A. (2021) · Cureus · doi:10.7759/cureus.17320 · Cited by 8
Trifan, A. V., Stratina, E., Năstasă, R., Rotaru, A., Stafie, R., Zenovia, S., Huiban, L., Sfarti, C. V., Cojocariu, C., Cuciureanu, T., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12071753 · Cited by 8
Li, Z., Liu, R., Gao, X., Hou, D., Leng, M., Zhang, Y., Du, M., Zhang, S., & Li, C. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01399-5 · Cited by 7
The Effects of Warm Acupuncture on the Expression of AMPK in High-Fat Diet-Induced MAFLD Rats
Lee, Y., Choi, D., Park, J., Kim, J. G., Choi, T., & Youn, D. H. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46100687 · Cited by 7
Yue, H., Jia, M., Li, B., Zong, A., Du, F., & Xu, T. (2024) · Journal of Food Science · doi:10.1111/1750-3841.17565 · Cited by 8
Decorin alleviates non-alcoholic fatty liver disease in rats with polycystic ovary syndrome
Elkattawy, H. A., Alsemeh, A. E., Ali, L. S., Ahmed, M. M., Eltaweel, A. M., Shaikh, F. M., Behiry, A., Hassan, A. E.-S., Sabir, D. K., Elsherbini, D. M. A., et al. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102689 · Cited by 7
Rao, Z., Geng, X. H., Huang, P., Wei, Q., Liu, S., Qu, C., & Zhao, J. (2024) · Experimental Physiology · doi:10.1113/ep092319 · Cited by 6
Deficiency of hepatokine orosomucoid1 aggravates NAFLD progression in mice
Sun, Y., Dai, X.-M., Yang, J., Chen, Y., Feng, J., Shi, X., Li, X., & Liu, X. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167654 · Cited by 7
Yang, X., Kuang, G., Gong, X., Xie, H., Lin, Y., Zhang, X., Chen, Z., Wan, J., & Li, Z. (2025) · Phytotherapy Research · doi:10.1002/ptr.8443 · Cited by 7
Xin, Z., Feng, L., Yu, Q., Shi, Y., Tang, T., Tong, X., Hu, S., You, Y., Zhang, S., Zhang, X., et al. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03888-x · Cited by 7
Yang, L., Zhai, J., Chen, Z., & Du, Y. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118273 · Cited by 7
Silva, V., Faria, H. O. F., Filho, C. P. B. S., de Alvarenga, J. F. R., Fiamoncini, J., & Otton, R. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109411 · Cited by 7
Gao, Q., Feng, L., Zhou, W., Li, X., Yin, L., & Wang, Y. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s418020 · Cited by 7
Srikanth, S., Garg, V., Subramanian, L., Verma, J., Sharma, H., Klair, H. S., Kavathia, S., Kolli, J. T. T., Vasireddy, N. S., Anmol, K., et al. (2024) · World Journal of Hepatology · doi:10.4254/wjh.v16.i6.912 · Cited by 7
Triterpenoids from Chios Mastiha Resin Against MASLD—A Molecular Docking Survey
Milošević, N., Milanović, M., Medic‐Stojanoska, M., Tipmanee, V., Smyrnioudis, I., Dedoussis, G. V., & Milić, N. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47010051 · Cited by 7
Molecular dissection of the role of ACE2 in glucose homeostasis
Chhabra, K. H., Shoemaker, R., Herath, C. B., Thomas, M. C., Filipeanu, C. M., & Lazartigues, E. D. (2025) · Physiological Reviews · doi:10.1152/physrev.00027.2024 · Cited by 8
Acyclovir alleviates insulin resistance via activating PKM1 in diabetic mice
Hu, Z., Zhou, J., Han, L., Li, X., Li, C., Wu, T., Liu, J., Zhao, W., Kang, J., & Chen, X. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120725 · Cited by 7
Association Between Serum Afamin Levels with Nonalcoholic Associated Fatty Liver Disease
Chen, S., Liu, Z., Li, C., Wang, J., Zhang, J., Zhang, X., & Xu, C. (2022) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2022/7175108 · Cited by 7
Insulin Resistance Markers to Detect Nonalcoholic Fatty Liver Disease in a Male Hispanic Population
Pérez-Mayorga, M., López-López, J., Chacón-Manosalva, M. A., Castillo, M. G., Otero, J. A., Martínez-Bello, D., Gómez-Arbeláez, D., Cohen, D. D., & López-Jaramillo, P. A. (2022) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2022/1782221 · Cited by 7
Herance, J. R., Martín‐Saladich, Q., Velásquez, M. A., Hernández, C., Aparicio, C., Ramírez, C., Ferrer, R., Giralt, M., Ballester, M. Á. G., Pericàs, J. M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158783 · Cited by 7
Zhang, Z., Li, L., Zhao, H., Zhou, L., Zhang, Z., Xiong, Y., & Yao, Y. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.07.010 · Cited by 8
Huang, Y.-M., Wu, Y.-S., Dang, Y., Xu, Y., Ma, K., & Dai, X.-Y. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01161-z · Cited by 7
Engineering-inspired approaches to study β-cell function and diabetes
Lewis, P. L., & Wells, J. M. (2021) · Stem Cells · doi:10.1002/stem.3340 · Cited by 8
Wu, H., He, X., Li, Q., Zheng, Y., Rayamajhi, S., Thapa, A., Meng, G., Zhang, Q. H., Liu, L., Wu, H., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.05.009 · Cited by 7
Fang, W. Y., Leng, X., Yun, B., Wang, L., & Qian, X. (2024) · Frontiers in Marine Science · doi:10.3389/fmars.2024.1474836 · Cited by 6
Xu, H., Jiang, N., Chen, G., He, Y., Xiong, J., Chen, D., Liu, Y., Wu, Y., & Zhao, C. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119937 · Cited by 8
Huang, S., Hu, W., & Fang, T. (2025) · PLoS ONE · doi:10.1371/journal.pone.0325961 · Cited by 6
Zhang, Y., Sun, J., Zhang, X., Zhong, Q., Hao, P., Yin, W., Chen, B., Wei, Q., Shen, H., Zhang, Y., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145713 · Cited by 6
Sukocheva, O. A., Ow, T., Harding, D., Mire, M. L., & Tse, E. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i7.106675 · Cited by 6
Liang, H., Zhang, D., Wei, N., Xi, P., Ge, H., & Zhang, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1652996 · Cited by 7
Molecular mechanisms mediated by liquid-liquid phase separation in chronic liver disease progression
Qiu, X., Tian, H., Gao, Y., Wang, J., Bao, Z., Qiu, N., Zhang, F., Zhang, Z., Wang, F., Zheng, S., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113843 · Cited by 7
Hepatokine fibrinogen-like protein 1 drives liver-kidney crosstalk to promote renal fibrosis
Wu, W., Zhu, L.-Z., Liu, K., Cao, L., Fan, Y., Zhou, P., Zhang, Y., Ma, G., Liu, J., Liu, B.-L., et al. (2026) · Nature Communications · doi:10.1038/s41467-025-68188-0 · Cited by 6
Cross-trait genomic modeling reveals the polygenic architecture and systemic impact of MASLD
Du, M., Yuan, H., Wu, T., Jiang, Y., Suo, C., Li, J., Zhang, T., Liu, Z., & Chen, X. (2026) · Science Advances · doi:10.1126/sciadv.aeb5665 · Cited by 7
Qian, Y., Sun, B., Zhang, Y., Zhang, M., Jiao, X., Lai, L., & Yang, W. (2022) · Annals of Palliative Medicine · doi:10.21037/apm-21-2988 · Cited by 6
Rspo3-mediated metabolic liver zonation regulates systemic glucose metabolism and body mass in mice
Uno, K., Uchino, T., SUZUKI, T. A., 遥平, 佐., Edo, N., uno, K., Morita, K., Ishikawa, T., Koizumi, M., Honda, H., et al. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3002955 · Cited by 8
Chen, P., Li, Y., Yang, C., & Zhang, Q. (2025) · Nutrition Journal · doi:10.1186/s12937-025-01170-0 · Cited by 6
Gaspar, T. B., Macedo, S., Sá, A., Soares, M. A., Rodrigues, D. F., Sousa, M., Mendes, N. M., Martins, R. S., Cardoso, L., Borges, I., et al. (2022) · Cancers · doi:10.3390/cancers14163865 · Cited by 6
Dilimulati, D., Du, L., Huang, X., Jayachandran, M., Cai, M., Zhang, Y., Zhou, D., Zhu, J., Su, L., Zhang, M., et al. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s374011 · Cited by 6
Petunina, N. A., Эдуардовна, Т. М., Валерьевна, Г. Е., Martirosian, N. S., & Кузина, И. А. (2022) · Terapevticheskii arkhiv · doi:10.26442/00403660.2022.10.201921 · Cited by 6
Wen, X., Wang, J., Fan, J., Chu, R., Chen, Y., Xing, Y., Li, N., & Wang, G. (2022) · Journal of Visualized Experiments · doi:10.3791/64816 · Cited by 6
Zhao, X., Zheng, J., Wang, J., Li, B., & Huang, W. (2024) · Biology · doi:10.3390/biology13010063 · Cited by 7
Geng, R., Guo, J., Lao, Y., Kang, S., Huang, K., & Tong, T. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.124933 · Cited by 6
Dilimulati, D., Cai, M., Lin, Z., Zhang, Y., Du, L., Zhou, D., Zhu, J., Su, L., Wang, Y., Zhang, M., et al. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05663-9 · Cited by 6
Increased Circulating Levels of Ectodysplasin A in Newly Diagnosed Type 2 Diabetic Patients
Deng, X., Cai, Z., Li, Y., Wu, X., Zhao, L., Li, H., Chen, K., Zhang, P., Wang, C., Zhao, Z., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.737624 · Cited by 6
Furuhashi, M., Higashiura, Y., Sakai, A., Koyama, M., Tanaka, M., Saitoh, S., Shimamoto, K., & Ohnishi, H. (2022) · Metabolites · doi:10.3390/metabo12030237 · Cited by 6
Mastromauro, C., Polidori, N., & Giannini, C. (2022) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001138 · Cited by 6
Islet cilia and glucose homeostasis
Melena, I., & Hughes, J. W. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1082193 · Cited by 7
Uehara, T., Wakui, H., & Tamura, K. (2023) · Hypertension Research · doi:10.1038/s41440-023-01241-x · Cited by 6
Chai, T. Y., George, J., Pasupathy, D., Cheung, N. W., & Rudland, V. L. (2025) · Nutrients · doi:10.3390/nu17101730 · Cited by 6
Hepatic ASPG-mediated lysophosphatidylinositol catabolism impairs insulin signal transduction
Li, F., Huang, H.-S., Zhao, Q., Zhang, W., Shi, T., Lv, W., Zhu, Q., Liu, H., Xu, Y., Huang, H., et al. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00525-x · Cited by 6
Wu, J., Zhang, X., Ma, X., Wei, Y., Wang, L., Du, Z., Xia, X., Che, L., Guo, D., Zheng, H., et al. (2025) · Advanced Science · doi:10.1002/advs.202507039 · Cited by 5
Nie, G., Liu, M., Yang, L., Li, C., Qu, C., Wang, J., Mei, J., Wang, Y., Han, L., Zhang, X., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1733950 · Cited by 5
Song, K., Yang, J., Lee, H. S., Oh, J. S., Kim, S., Lee, M., Suh, J., Kwon, A., Kim, H.-S., & Chae, H. W. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1166244 · Cited by 5
Wang, W., Chen, Y., Tu, M., & Chen, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1384059 · Cited by 5
Alisol B alleviates MASLD by activating liver autophagy and fatty acid oxidation via Ces2a
Zhang, C., Chen, L., Jiang, Y., Qiu, J., Lin, Y., Ren, G. R., Xu, F., Xi, J., Yu, Z., Rong, X., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114768 · Cited by 5
Rathi, A., Goswami, D., Garg, A., Kaushik, S., & Dhiman, N. (2025) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.16335 · Cited by 5
From complement to complosome in non‐alcoholic fatty liver disease: When location matters
Nguyen, V., Hughes, T. R., & Zhou, Y. (2023) · Liver International · doi:10.1111/liv.15796 · Cited by 6
Obesity induced Ext1 reduction mediates the occurrence of NAFLD
Wang, M., Li, B., Qin, F., Ye, J., & Jin, L. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.12.017 · Cited by 6
Sclerocarya birrea (Marula) Extract Inhibits Hepatic Steatosis in db/db Mice
Mabasa, L., Kotze, A., Shabalala, S. C., Kimani, C. N., Gabuza, K., Johnson, R., Sangweni, N. F., Maharaj, V. J., & Muller, C. J. F. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19073782 · Cited by 5
A brown fat-enriched adipokine, ASRA, is a leptin receptor antagonist that stimulates appetitePreprint
Huang, L., Liu, P., Du, Y., Bazán, J. F., Pan, D., Chen, Q., Lee, A., Kola, V. S. R., Wolfe, S. A., & Wang, Y. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.12.557454 · Cited by 5
Yin, Y., Guo, H., Chen, J., Yang, Y., Li, X., & Zhang, X. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402772 · Cited by 4
Barigou, M., Ramzan, I., & Chartoumpekis, D. V. (2025) · Biomedicines · doi:10.3390/biomedicines13081792 · Cited by 4
Eryptosis in Liver Diseases: Contribution to Anemia and Hypercoagulation
Kurmangaliyeva, S. S., Baktikulova, K., Tkachenko, A. S., Seitkhanova, B., Tryfonyuk, L., Rakhimzhanova, F. S., Yussupov, R., & Kurmangaliyev, K. B. (2025) · Medical Sciences · doi:10.3390/medsci13030125 · Cited by 4
Fu, L., Xie, J., Wang, Z., Jiang, T., Zeng, Y., Yan, J., Sun, R., Huang, M., Du, S., Wang, X., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157246 · Cited by 4
The role of hypothalamus in the pathophysiological process of MASLD and advances in drug discovery
Wei, S., Dong, Y., Wang, Y., Li, G., Zhao, Y., & Zheng, R. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107972 · Cited by 4
Yu, Y., Hou, Y., Fu, Y., Yi, L., Gou, Z., Wang, Y., Xue, Y., Xi, J., Xing, R., & Hu, M. (2025) · npj gut and liver. · doi:10.1038/s44355-025-00042-y · Cited by 4
Gomha, S. M., Al‐Hussain, S. A., Farag, B., Abolibda, T. Z., Nayl, A. A., Saeed, A., Sayed, A. R., & Zaki, M. E. A. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70638 · Cited by 4
Jiang, S., Zhai, L., Shao, Y., Sun, F., & Liu, X. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1743899 · Cited by 5
MASLD and the cardiovascular-kidney-liver-metabolic syndrome
Angelidi, A. M., Boutari, C., Kokkorakis, M., Stefanakis, K., Mikhailidis, D. P., Jacob, G., & Mantzoros, C. S. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag023 · Cited by 6
Forst, T. M., Botz, I., Berse, M., Voswinkel, S., Strempler, M.-E., Baumann, S., & Marinez, M. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01378-z · Cited by 4
Adropin expression reflects circadian, lipoprotein, and mitochondrial processes in human tissues
Stevens, J. R., Clemence, G., Zhou, M., Gamie, F., Aggarwal, G., McMillan, R. P., Hulver, M. W., Martinez, L. O., van der Brug, M., Vellas, B. J., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102196 · Cited by 8
Kwak, J. H., Lee, H., Jeong, S.-T., Lee, J., Lee, M., & Paik, J. K. (2021) · Trials · doi:10.1186/s13063-021-05656-0 · Cited by 4
Zhang, M., Tang, L., Cui, X., Yu, T., Li, Z., Li, X., & Li, G. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01097-w · Cited by 4
Gong, Q., Zhang, X., Sun, Y., Shen, J., Li, X., Xue, C., & Liu, Z. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02256-6 · Cited by 4
Metadata
- Authors
- Watt, M. J., Miotto, P. M., De Nardo, W., & Montgomery, M. K.
- Affiliations
- The University of Melbourne (AU)
- Department of Physiology, University of Melbourne, Melbourne, Victoria, Australia
- Corresponding author
- Watt, Matthew J
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2019-04-25
- Volume
- 40
- Issue
- 5
- Pages
- 1367-1393
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2942227779
- Cited by
- 615
- References
- 385
- Citations by year
- 2026: 61 · 2025: 98 · 2024: 109 · 2023: 98 · 2022: 128 · 2021: 83 · 2020: 31 · 2019: 7
- FWCI
- 9.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Health and Medical Research Council (APP1077703, APP1143224, APP1162511, APP1156508)
- Natural Sciences and Engineering Research Council of Canada
- Melbourne Research Scholarship, University of Melbourne (AU)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- non-alcoholic fatty liver disease, insulin resistance, hepatokines, hepatic lipid metabolism, microRNA, extracellular vesicles, exosomes, type 2 diabetes, muscle metabolism, adipose tissue, pancreas
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Endocrine Glands, Humans, Insulin Resistance, Liver, Dyslipidemias, Lipid Metabolism, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
